Not applicableUnknownNCT04262921What this trial is testingFrench COVID CohortWho this might be right forCoronavirus Infections Institut National de la Santé Et de la Recherche Médicale, France 4,415
Not applicableStudy completedNCT04725084What this trial is testingComparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress SyndromeWho this might be right forSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 355
Not applicableUnknownNCT04465474What this trial is testingCoronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)Who this might be right forCOVID-19 Chinese University of Hong Kong 3,000
Not applicableStudy completedNCT05364268What this trial is testingEvaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical ValidationWho this might be right for2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+6 more AudibleHealth AI, Inc. 514
Early research (Phase 1)Study completedNCT05181683What this trial is testingCOVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult VolunteersWho this might be right forHealthyChronic Stable Illness Regeneron Pharmaceuticals 45
Early research (Phase 1)Study completedNCT05544786What this trial is testingRelative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.Who this might be right forBiological Availability Pfizer 12
Not applicableWithdrawnNCT04945590What this trial is testingThe VIDA After COVID StudyWho this might be right forCovid19 Mayo Clinic
Not applicableStudy completedNCT04591873What this trial is testingUsing Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency DepartmentWho this might be right forCritical IllnessInfections, RespiratoryEmergency Service, Hospital+1 more National Taiwan University Hospital 74
Not applicableStudy completedNCT05501288What this trial is testingHuashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019Who this might be right forCoronavirus Disease 2019 Shanghai Children's Medical Center 108
Early research (Phase 1)Ended earlyNCT05027815What this trial is testingTregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)Who this might be right forAcute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV Jeffrey Bluestone 7
Not applicableUnknownNCT04479982What this trial is testingMicrobial Infection and AMR in Hospitalized Patients With Covid 19Who this might be right forCovid19 Assiut University 70
Not applicableEnded earlyNCT05252910What this trial is testingSpecimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and AdolescentsWho this might be right forCOVID-19 Pharm-Olam, LLC 33
Not applicableStudy completedNCT05648799What this trial is testingPharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia)Who this might be right forPharmacokineticsSafety IssuesEfficacy Geropharm 246
Early research (Phase 1)Study completedNCT07235137What this trial is testingLearn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese AdultsWho this might be right forHealthy Participant Pfizer 12
Early research (Phase 1)Ended earlyNCT05092581What this trial is testingCOVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19Who this might be right forCOVID-19 Regeneron Pharmaceuticals 2
Large-scale testing (Phase 3)Ended earlyNCT04502472What this trial is testingTreatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent PlasmaWho this might be right forCovid-19 Inova Health Care Services 109
Testing effectiveness (Phase 2)Study completedNCT04275245What this trial is testingClinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV PneumoniaWho this might be right forCoronavirus Disease 2019 (COVID-19) Tang-Du Hospital 17
Testing effectiveness (Phase 2)UnknownNCT04377334What this trial is testingMesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)Who this might be right forARDSCOVID-19 University Hospital Tuebingen 40
Testing effectiveness (Phase 2)Ended earlyNCT04370834What this trial is testingTocilizumab for Patients With Cancer and COVID-19 DiseaseWho this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more National Cancer Institute (NCI) 1
Not applicableStudy completedNCT04390165What this trial is testingMalaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional StudyWho this might be right forSARS-CoV InfectionCOVID-19Anosmia+1 more Hospital Sultanah Bahiyah 498